Table 2.
Country | n | Mean age/age | HIV (%) | HBV (%) | HCV (%) | HIV-HBV co-infection (%) | HIV-HCV co-infection (%) | Triple infection (%) | Ref. |
FSWs | |||||||||
Lebanon | 103a | ≥ 18 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | [23] |
Libya | 69a | ≥ 15 | 10.1 | 2.9 | 7.2 | 0.0 | 4.3 | 0.0 | [24] |
Turkey | 130 | 38.9 | 0.0 | 3.1 | 0.8 | 0.0 | 0.0 | 0.0 | [25] |
MSM | |||||||||
Lebanon | 101a | ≥ 18 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | [23] |
Libya | 227a | ≥ 15 | 5.3 | 3.1 | 8.4 | 0.0 | 4.4 | 0.0 | [24] |
Non-adjusted prevalence using respondent-driven sampling method. All numbers were rounded to the nearest 1. HIV: Human immunodeficiency virus; HBV: Hepatitis B virus; HCV: Hepatitis C virus.